The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery
10.3760/cma.j.issn.0253-3766.2018.05.006
- VernacularTitle: 初次保乳手术腋窝淋巴结状态对乳腺癌患者局部区域复发后预后的影响
- Author:
Zhen ZHANG
1
,
2
,
3
,
4
,
5
;
Wei ZHANG
1
,
2
,
3
,
4
,
5
;
Zijie LI
1
,
2
,
3
,
4
,
5
;
Ximei WANG
1
,
2
,
3
,
4
,
5
;
Xuchen CAO
1
,
2
,
3
,
4
,
5
;
Chunhua XIAO
1
,
2
,
3
,
4
,
5
Author Information
1. Galactophore Department, Tianjin Medical University Cancer Institute and Hospital
2. National Clinical Research Center for Cancer
3. Key Laboratory of Cancer Prevention and Therapy, Tianjin
4. Tianjin′s Clinical Research Center for Cancer
5. Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China
- Publication Type:Clinical Trail
- Keywords:
Breast neoplasms;
Breast-conserving surgery;
Neoplasm recurrence, local;
Neoplasm recurrence, regional;
Axillary lymph node;
Prognosis
- From:
Chinese Journal of Oncology
2018;40(5):347-351
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of axillary lymph node status in evaluating the prognosis of patients with local recurrence after breast-conserving surgery.
Methods:The clinical data of 72 patients with local-regional recurrence who had undergone breast-conserving therapy in Tianjin Cancer Hospital from February 2001 to December 2009 were collected and retrospectively analyzed. These patients were divided into axillary lymph node positive group (23 cases) and negative group (49 cases), according to their axillary lymph node status.
Results:Among 72 patients, 21 cases were local recurrence, 35 cases were regional recurrence, and 16 cases were local-regional recurrence. In the axillary lymph node positive group, 7 cases were local recurrence, 10 cases were regional recurrence, 6 cases were local-regional recurrence. In the axillary lymph node negative group, 14 cases were local recurrence, 25 cases were regional recurrence, 10 cases were local-regional recurrence. There was no significant difference between these two groups (P=0.807). Moreover, no significant differences of the age, recurrent site, estrogen receptor (ER) and/or progesterone receptor (PR) status, human epidermal growth factor receptor 2 (HER-2) status, disease-free period, local and systemic therapeutic effect, non-distant metastasis survival between these two groups were observed (P>0.05). However, the overall survival of axillary lymph node positive group after recurrence was significantly lower than that of negative group (P=0.014). Cox multivariate analysis showed that recurrent site is an independent prognostic factor of disease-free survival of patients with regional recurrence after breast-conserving surgery (OR=2.050, P=0.002). The axillary lymph node status and recurrent site were independent prognostic factors of overall survival of these patients (OR=3.469, P=0.003; OR=3.676, P<0.001).
Conclusions:Axillary lymph node status is an independent factor of overall survival of patients with regional recurrence after breast-conserving surgery, but it is marginally related with their non-distant metastasis survival.
